3Boiziau C, Dausse E, Yurchenko L, et al. DNA aptamers selected against the HIV-1 trans-aetivation-responsive RNA element form RNA-DNA kissing complexes [ J ]. J Biol Chem, 1999,274 (18) : 12730-12737.
4Osborne S E, Volker J, Stevens S Y, et al. Design, synthesis,and analysis of disulfide cross-linked DNA duplexes [J]. JAm Chem Soc,1996,118(48) :11993-12003.
5Schmidt K S, Borkowski S, Kurreck J ,et al. Application of locked nucleic acids to improve aptamer in vivo stability and targeting function [ J ]. Nucleic Acids Res, 2004, 32 (19) :5757-5765.
6Darfeuille F, Arzumanov A, Gryaznov S, et al. Loop-loop interaction of I-IIV-1 TAR RNA with N3'→P5' deoxyphosphoramidate aptamers inhibits in vitro Tat-mediated transcription[J]. Proc Natl Acad Sci USA,2002,99 ( 15): 9709-9714.
7Zhang Z, Blank M, Schluesener H J. Nucleic acid aptamers in human viral disease [ J ]. Arch Immunol Ther Exp, 2004,52(5) :307-315.
8Guo K T, Ziemer G, Paul A, et al. CELL-SELEX: Novel perspectives of aptamer-based therapeutics [ J ].Int J Mol Sci,2008,9(4) :668-678.
9Mukhopadhyay R. Aptamers are ready for the spotlight [ J ]. Anal Chem,2005,77 (5) : 114A-118A.
10Shangguan D H, Li Y, Tang Z W, et al. Aptamers evolved from live cells as effective molecular probes for cancer study [ J ]. Proc Natl Acad Sci USA, 2006, 103 ( 32 ) : 11838-11843.
